Simvastatin	O
induces	O
apoptosis	O
of	O
B	B-Cell
-	I-Cell
CLL	I-Cell
cells	I-Cell
by	O
activation	O
of	O
mitochondrial	B-Cellular_component
caspase	O
9	O
.	O

BACKGROUND	O
AND	O
OBJECTIVES	O
:	O
Chronic	B-Cancer
lymphocytic	I-Cancer
leukemia	I-Cancer
(	O
CLL	B-Cancer
)	O
is	O
the	O
most	O
common	O
leukemia	B-Cancer
in	O
the	O
western	O
world	O
.	O

Despite	O
several	O
advances	O
in	O
therapeutic	O
options	O
,	O
the	O
disease	O
remains	O
incurable	O
.	O

Recently	O
,	O
it	O
was	O
repeatedly	O
demonstrated	O
that	O
statins	O
,	O
competitive	O
inhibitors	O
of	O
3	O
-	O
hydroxy	O
-	O
3	O
-	O
methyl	O
glutaryl	O
coenzyme	O
A	O
(	O
HMG	O
-	O
CoA	O
)	O
reductase	O
,	O
have	O
antineoplastic	B-Cancer
effects	O
.	O

Therefore	O
we	O
aimed	O
to	O
study	O
the	O
effects	O
of	O
simvastatin	O
(	O
Sim	O
)	O
on	O
malignant	B-Cell
B	I-Cell
cells	I-Cell
derived	O
from	O
patients	O
with	O
CLL	B-Cancer
and	O
mechanisms	O
of	O
action	O
of	O
the	O
drug	O
.	O

METHODS	O
AND	O
RESULTS	O
:	O
Purified	O
B	B-Cell
-	I-Cell
CLL	I-Cell
cells	I-Cell
from	O
15	O
patients	O
were	O
cultured	O
either	O
alone	O
or	O
with	O
Sim	O
at	O
concentrations	O
of	O
10	O
,	O
50	O
,	O
and	O
100	O
microM	O
.	O

Viability	O
,	O
measured	O
by	O
the	O
activity	O
of	O
mitochondrial	B-Cellular_component
dehydrogenases	O
,	O
was	O
reduced	O
significantly	O
in	O
the	O
cells	B-Cell
treated	O
with	O
Sim	O
at	O
50	O
and	O
100	O
microM	O
for	O
24	O
hours	O
(	O
p	O
<	O
0	O
.	O
005	O
)	O
.	O

The	O
level	O
of	O
apoptosis	O
,	O
as	O
measured	O
by	O
annexin	O
binding	O
to	O
exposed	O
phosphatidylserine	O
moieties	O
,	O
increased	O
significantly	O
in	O
the	O
treated	O
cells	B-Cell
at	O
concentrations	O
higher	O
than	O
50	O
microM	O
for	O
24	O
hours	O
(	O
p	O
<	O
0	O
.	O
003	O
)	O
.	O

The	O
level	O
of	O
necrosis	O
,	O
as	O
measured	O
by	O
propidium	O
iodide	O
internalization	O
,	O
increased	O
significantly	O
after	O
24	O
hours	O
exposure	O
to	O
Sim	O
at	O
50	O
microM	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

The	O
apoptotic	O
cascade	O
was	O
studied	O
by	O
immunoblot	O
analysis	O
of	O
caspases	O
following	O
Sim	O
treatment	O
.	O

These	O
showed	O
cleavage	O
of	O
caspases	O
9	O
,	O
8	O
,	O
and	O
3	O
.	O

Addition	O
of	O
the	O
caspase	O
inhibitor	O
Z	O
-	O
VAD	O
.	O
fmk	O
inhibited	O
caspase	O
8	O
and	O
3	O
significantly	O
but	O
did	O
not	O
affect	O
caspase	O
9	O
.	O

CONCLUSION	O
:	O
Exposure	O
of	O
clonal	B-Cell
B	I-Cell
lymphocytes	I-Cell
from	O
patients	O
with	O
CLL	B-Cancer
to	O
simvastatin	O
decreases	O
viability	O
significantly	O
by	O
the	O
induction	O
of	O
apoptosis	O
.	O

The	O
apoptosis	O
induced	O
by	O
Sim	O
is	O
probably	O
initiated	O
by	O
the	O
mitochondrial	B-Cellular_component
caspase	O
9	O
,	O
which	O
indirectly	O
leads	O
to	O
activation	O
of	O
caspase	O
3	O
and	O
8	O
.	O

